Viewing Study NCT00921167


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-02-10 @ 12:25 AM
Study NCT ID: NCT00921167
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 2009-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas
Sponsor: Clinical Research Center for Solid Tumor, Korea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Astrocytoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioblastoma View
None Astrocytoma View
None Chemotherapy View